Pharmacist by training and successful serial entrepreneur with a proven track record of founding and scaling multiple companies. As CEO and founder of Ziphius, I lead the development of next-generation RNA medicines leveraging self-amplifying RNA and lipid nanoparticle technologies to address infectious diseases, rare diseases, and oncology. With proven expertise in business development, team building, product innovation, technology adoption, and strategic partnerships, I am committed to driving growth and long-term value creation. Passionate about transforming patient care, I am motivated by a mission to unite business success with purpose —delivering life-changing therapies that positively impact patients and their families.